Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 492

1.

Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.

Chen EC, Werner L, Hobbs GS, Narayan R, Amrein PC, Fathi AT, Brunner AM.

Leuk Lymphoma. 2019 May 23:1-5. doi: 10.1080/10428194.2019.1617863. [Epub ahead of print] No abstract available.

PMID:
31120366
2.

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study.

Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J, Menghrajani K, Shaw C, Baer MR, Elliott MA, Perl AE, Ráčil Z, Mayer J, Zak P, Szotkowski T, de Botton S, Grimwade D, Mayer K, Walter RB, Krämer A, Burnett AK, Ho AD, Platzbecker U, Thiede C, Ehninger G, Stone RM, Röllig C, Tallman MS, Estey EH, Müller-Tidow C, Russell NH, Schlenk RF, Levis MJ.

Haematologica. 2019 Apr 19. pii: haematol.2018.208678. doi: 10.3324/haematol.2018.208678. [Epub ahead of print]

3.

TV vs. YouTube: TV Advertisements Capture More Visual Attention, Create More Positive Emotions and Have a Stronger Impact on Implicit Long-Term Memory.

Weibel D, di Francesco R, Kopf R, Fahrni S, Brunner A, Kronenberg P, Lobmaier JS, Reber TP, Mast FW, Wissmath B.

Front Psychol. 2019 Mar 21;10:626. doi: 10.3389/fpsyg.2019.00626. eCollection 2019.

4.

Populus trichocarpa clade A PP2C protein phosphatases: their stress-induced expression patterns, interactions in core abscisic acid signaling, and potential for regulation of growth and development.

Rigoulot SB, Petzold HE, Williams SP, Brunner AM, Beers EP.

Plant Mol Biol. 2019 Jun;100(3):303-317. doi: 10.1007/s11103-019-00861-7. Epub 2019 Apr 3.

PMID:
30945147
5.

Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.

El-Jawahri A, Abel GA, Traeger L, Waldman L, Markovitz N, VanDusen H, Fathi A, Steensma DP, LeBlanc TW, Horick NK, DeAngelo DJ, Wadleigh M, Hobbs G, Foster J, Brunner AM, Amrein P, Stone RM, Temel JS, Greer JA.

Leukemia. 2019 Mar 28. doi: 10.1038/s41375-019-0449-1. [Epub ahead of print]

PMID:
30923318
6.

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.

Degasper C, Brunner A, Sampson N, Tsibulak I, Wieser V, Welponer H, Marth C, Fiegl H, Zeimet AG.

Tumour Biol. 2019 Feb;41(2):1010428319830002. doi: 10.1177/1010428319830002.

PMID:
30813866
7.

Site-specific ubiquitylation and SUMOylation using genetic-code expansion and sortase.

Fottner M, Brunner AD, Bittl V, Horn-Ghetko D, Jussupow A, Kaila VRI, Bremm A, Lang K.

Nat Chem Biol. 2019 Mar;15(3):276-284. doi: 10.1038/s41589-019-0227-4. Epub 2019 Feb 15.

PMID:
30770915
8.

Digital PCR in bone marrow trephine biopsies is highly sensitive for MYD88L265P detection in lymphomas with plasmacytic/plasmacytoid differentiation.

Willenbacher E, Willenbacher W, Wolf DG, Zelger B, Peschel I, Manzl C, Haun M, Brunner A.

Br J Haematol. 2019 Feb 14. doi: 10.1111/bjh.15792. [Epub ahead of print] No abstract available.

PMID:
30763982
9.

MaxQuant.Live Enables Global Targeting of More Than 25,000 Peptides.

Wichmann C, Meier F, Virreira Winter S, Brunner AD, Cox J, Mann M.

Mol Cell Proteomics. 2019 May;18(5):982-994. doi: 10.1074/mcp.TIR118.001131. Epub 2019 Feb 12.

10.

RNA interference suppression of AGAMOUS and SEEDSTICK alters floral organ identity and impairs floral organ determinacy, ovule differentiation, and seed-hair development in Populus.

Lu H, Klocko AL, Brunner AM, Ma C, Magnuson AC, Howe GT, An X, Strauss SH.

New Phytol. 2019 Apr;222(2):923-937. doi: 10.1111/nph.15648. Epub 2019 Jan 19.

PMID:
30565259
11.

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system.

French CD, Willoughby RE, Pan A, Wong SJ, Foley JF, Wheat LJ, Fernandez J, Encarnacion R, Ondrush JM, Fatteh N, Paez A, David D, Javaid W, Amzuta IG, Neilan AM, Robbins GK, Brunner AM, Hu WT, Mishchuk DO, Slupsky CM.

PLoS Negl Trop Dis. 2018 Dec 17;12(12):e0007045. doi: 10.1371/journal.pntd.0007045. eCollection 2018 Dec.

12.

Strategies for Engineering Reproductive Sterility in Plantation Forests.

Fritsche S, Klocko AL, Boron A, Brunner AM, Thorlby G.

Front Plant Sci. 2018 Nov 15;9:1671. doi: 10.3389/fpls.2018.01671. eCollection 2018.

13.

Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.

Brunner AM, Neuberg DS, Wander SA, Sadrzadeh H, Ballen KK, Amrein PC, Attar E, Hobbs GS, Chen YB, Perry A, Connolly C, Joseph C, Burke M, Ramos A, Galinsky I, Yen K, Yang H, Straley K, Agresta S, Adamia S, Borger DR, Iafrate A, Graubert TA, Stone RM, Fathi AT.

Cancer. 2019 Feb 15;125(4):541-549. doi: 10.1002/cncr.31729. Epub 2018 Nov 13.

PMID:
30422308
14.

Online Parallel Accumulation-Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer.

Meier F, Brunner AD, Koch S, Koch H, Lubeck M, Krause M, Goedecke N, Decker J, Kosinski T, Park MA, Bache N, Hoerning O, Cox J, Räther O, Mann M.

Mol Cell Proteomics. 2018 Dec;17(12):2534-2545. doi: 10.1074/mcp.TIR118.000900. Epub 2018 Nov 1.

15.

Prioritizing anthropogenic chemicals in drinking water and sources through combined use of mass spectrometry and ToxCast toxicity data.

Brunner AM, Dingemans MML, Baken KA, van Wezel AP.

J Hazard Mater. 2019 Feb 15;364:332-338. doi: 10.1016/j.jhazmat.2018.10.044. Epub 2018 Oct 18.

16.

Screw tip augmentation leads to improved primary stability in the minimally invasive treatment of displaced intra-articular fractures of the calcaneus: a biomechanical study.

Eichinger M, Brunner A, Stofferin H, Bölderl A, Blauth M, Schmölz W.

Int Orthop. 2018 Oct 10. doi: 10.1007/s00264-018-4171-9. [Epub ahead of print]

PMID:
30306219
17.

Monitoring transformation product formation in the drinking water treatments rapid sand filtration and ozonation.

Brunner AM, Vughs D, Siegers W, Bertelkamp C, Hofman-Caris R, Kolkman A, Ter Laak T.

Chemosphere. 2019 Jan;214:801-811. doi: 10.1016/j.chemosphere.2018.09.140. Epub 2018 Sep 26.

18.

Results of universal ultrasound screening for developmental dysplasia of the hip: a prospective follow-up of 28 092 consecutive infants.

Biedermann R, Riccabona J, Giesinger JM, Brunner A, Liebensteiner M, Wansch J, Dammerer D, Nogler M.

Bone Joint J. 2018 Oct;100-B(10):1399-1404. doi: 10.1302/0301-620X.100B10.BJJ-2017-1539.R2.

PMID:
30295526
19.

Clustered incidence of adult acute promyelocytic leukemia.

Brunner AM, Kim PG, Sadrzadeh H, Drapkin BJ, Sprague KA, Sloan JM, Chai-Ho W, Bhargava P, Pozdnyakova O, Fathi AT.

Leuk Res. 2018 Nov;74:47-50. doi: 10.1016/j.leukres.2018.09.008. Epub 2018 Sep 19. No abstract available.

PMID:
30292128
20.

Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions.

Steensma DP, Brunner AM, DeZern AE, Garcia-Manero G, Komrokji RS, Odenike OS, Roboz GJ, Savona MR, Stone RM, Sekeres MA.

Cancer. 2018 Dec 15;124(24):4601-4609. doi: 10.1002/cncr.31769. Epub 2018 Oct 5.

PMID:
30289970
21.

Clinical infrared microscopic imaging: An overview.

Pallua JD, Brunner A, Zelger B, Stalder R, Unterberger SH, Schirmer M, Tappert MC.

Pathol Res Pract. 2018 Oct;214(10):1532-1538. doi: 10.1016/j.prp.2018.08.026. Epub 2018 Sep 4. Review.

PMID:
30220435
22.

Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.

Sanford NN, Miao R, Wang H, Goldberg S, Jacobson A, Brunner AM, Cote GM, Yock TI, Ebb DH, Chen YB, Jee KW, Hornicek F, DeLaney TF, Choy E, Chen YL.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):52-61. doi: 10.1016/j.ijrobp.2018.08.037. Epub 2018 Aug 28.

PMID:
30165126
23.

Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.

El-Jawahri A, Nelson-Lowe M, VanDusen H, Traeger L, Abel GA, Greer JA, Fathi A, Steensma DP, LeBlanc TW, Li Z, DeAngelo D, Wadleigh M, Hobbs G, Foster J, Brunner A, Amrein P, Stone RM, Temel JS.

Oncologist. 2019 Feb;24(2):247-254. doi: 10.1634/theoncologist.2018-0317. Epub 2018 Aug 23.

PMID:
30139841
24.

Phenotypic Expression and Stability in a Large-Scale Field Study of Genetically Engineered Poplars Containing Sexual Containment Transgenes.

Klocko AL, Lu H, Magnuson A, Brunner AM, Ma C, Strauss SH.

Front Bioeng Biotechnol. 2018 Aug 3;6:100. doi: 10.3389/fbioe.2018.00100. eCollection 2018.

25.

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort.

Stahl M, DeVeaux M, de Witte T, Neukirchen J, Sekeres MA, Brunner AM, Roboz GJ, Steensma DP, Bhatt VR, Platzbecker U, Cluzeau T, Prata PH, Itzykson R, Fenaux P, Fathi AT, Smith A, Germing U, Ritchie EK, Verma V, Nazha A, Maciejewski JP, Podoltsev NA, Prebet T, Santini V, Gore SD, Komrokji RS, Zeidan AM.

Blood Adv. 2018 Jul 24;2(14):1765-1772. doi: 10.1182/bloodadvances.2018019414.

26.

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes.

Brunner AM, Weng S, Cronin A, Fathi AT, Habib AR, Stone R, Graubert T, Steensma DP, Abel GA.

Am J Hematol. 2018 Sep;93(9):1119-1126. doi: 10.1002/ajh.25166. Epub 2018 Aug 28.

PMID:
30033577
27.

Repurposing an Old Drug for a New Epidemic: Ursodeoxycholic Acid to Prevent Recurrent Clostridioides difficile Infection.

Webb BJ, Brunner A, Lewis J, Ford CD, Lopansri BK.

Clin Infect Dis. 2019 Jan 18;68(3):498-500. doi: 10.1093/cid/ciy568.

PMID:
30020421
28.

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM.

Leuk Lymphoma. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893. Epub 2018 Jul 2. No abstract available.

PMID:
29963936
29.

Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients.

Pichler R, Fritz J, Lackner F, Sprung S, Brunner A, Horninger W, Loidl W, Pircher A, Heidegger I.

Clin Genitourin Cancer. 2018 Oct;16(5):e1015-e1024. doi: 10.1016/j.clgc.2018.05.015. Epub 2018 Jun 8.

PMID:
29960831
30.

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML.

Chen EC, Fathi AT, Brunner AM.

Onco Targets Ther. 2018 Jun 12;11:3425-3434. doi: 10.2147/OTT.S141212. eCollection 2018. Review.

31.

Incident adverse events following therapy for acute promyelocytic leukemia.

Kim PG, Bridgham K, Chen EC, Vidula MK, Pozdnyakova O, Brunner AM, Fathi AT.

Leuk Res Rep. 2018 May 5;9:79-83. doi: 10.1016/j.lrr.2018.05.001. eCollection 2018.

32.

Outcomes and predictors of survival in blast phase myeloproliferative neoplasms.

Lancman G, Brunner A, Hoffman R, Mascarenhas J, Hobbs G.

Leuk Res. 2018 Jul;70:49-55. doi: 10.1016/j.leukres.2018.05.004. Epub 2018 May 21.

PMID:
29807273
33.
34.

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.

Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP 3rd, Chen YA, Fathi AT, Graubert TA, Brunner AM, Wadleigh M, Stone RM, DeAngelo DJ, Nardi V, Hasserjian RP, Weinberg OK.

Blood. 2018 Jun 21;131(25):2816-2825. doi: 10.1182/blood-2018-01-828467. Epub 2018 May 3.

PMID:
29724895
35.

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM.

Blood Adv. 2018 Apr 24;2(8):923-932. doi: 10.1182/bloodadvances.2018016121.

36.

Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1754-1758. doi: 10.1016/j.bbmt.2018.03.025. Epub 2018 Apr 9.

PMID:
29649620
37.

High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.

Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R.

Cancer Sci. 2018 May;109(5):1583-1591. doi: 10.1111/cas.13560. Epub 2018 Apr 16.

38.

No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.

Brunner AM.

Acta Haematol. 2018;139(2):128-130. doi: 10.1159/000487071. Epub 2018 Feb 14. No abstract available.

39.

Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.

Sanford NN, Martin AM, Brunner AM, Cote GM, Choy E, DeLaney TF, Aizer AA, Chen YL.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):687-694. doi: 10.1016/j.ijrobp.2017.11.011. Epub 2017 Nov 14.

PMID:
29413281
40.

Prevalence of Cam and Pincer Deformities in the X-Rays of Asymptomatic Individuals.

Thier S, Gerisch D, Weiss C, Fickert S, Brunner A.

Biomed Res Int. 2017;2017:8562329. doi: 10.1155/2017/8562329. Epub 2017 Dec 18.

41.

DIVARICATA AND RADIALIS INTERACTING FACTOR (DRIF) also interacts with WOX and KNOX proteins associated with wood formation in Populus trichocarpa.

Petzold HE, Chanda B, Zhao C, Rigoulot SB, Beers EP, Brunner AM.

Plant J. 2018 Mar;93(6):1076-1087. doi: 10.1111/tpj.13831. Epub 2018 Feb 23.

42.

Benefit of 18F-fluorocholine PET imaging in parathyroid surgery.

Huber GF, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann PA, von Schulthess GK.

Eur Radiol. 2018 Jun;28(6):2700-2707. doi: 10.1007/s00330-017-5190-4. Epub 2018 Jan 25.

PMID:
29372312
43.

Genomics in childhood acute myeloid leukemia comes of age.

Brunner AM, Graubert TA.

Nat Med. 2018 Jan 9;24(1):7-9. doi: 10.1038/nm.4469. No abstract available.

PMID:
29315296
44.

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes.

Brunner AM, Blonquist TM, Hobbs GS, Amrein PC, Neuberg DS, Steensma DP, Abel GA, Fathi AT.

Blood Adv. 2017 Oct 18;1(23):2032-2040. doi: 10.1182/bloodadvances.2017010165. eCollection 2017 Oct 24.

45.

Implementation and Evaluation of an Economic Model for Telestroke: Experience from Virtuall, France.

Riou-Comte N, Mione G, Humbertjean L, Brunner A, Vezain A, Lavandier K, Marchal S, Bracard S, Debouverie M, Richard S.

Front Neurol. 2017 Nov 20;8:613. doi: 10.3389/fneur.2017.00613. eCollection 2017.

46.

Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling.

Sassi Y, Avramopoulos P, Ramanujam D, Grüter L, Werfel S, Giosele S, Brunner AD, Esfandyari D, Papadopoulou AS, De Strooper B, Hübner N, Kumarswamy R, Thum T, Yin X, Mayr M, Laggerbauer B, Engelhardt S.

Nat Commun. 2017 Nov 20;8(1):1614. doi: 10.1038/s41467-017-01737-4.

47.

Cognitive reappraisal and acceptance: Effects on emotion, physiology, and perceived cognitive costs.

Troy AS, Shallcross AJ, Brunner A, Friedman R, Jones MC.

Emotion. 2018 Feb;18(1):58-74. doi: 10.1037/emo0000371. Epub 2017 Nov 20.

48.

RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.

Fischer MM, Yeung VP, Cattaruzza F, Hussein R, Yen WC, Murriel C, Evans JW, O'Young G, Brunner AL, Wang M, Cain J, Cancilla B, Kapoun A, Hoey T.

Sci Rep. 2017 Nov 10;7(1):15270. doi: 10.1038/s41598-017-15704-y.

49.

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

DeAngelo DJ, Brunner AM, Werner L, Avigan D, Fathi AT, Sperling AS, Washington A, Stroopinsky D, Rosenblatt J, McMasters M, Luptakova K, Wadleigh M, Steensma DP, Hobbs GS, Attar EC, Amrein PC, Ebert BL, Stone RM, Ballen KK.

Am J Hematol. 2018 Feb;93(2):254-261. doi: 10.1002/ajh.24968. Epub 2017 Nov 21.

50.

Identification of new protein-protein and protein-DNA interactions linked with wood formation in Populus trichocarpa.

Petzold HE, Rigoulot SB, Zhao C, Chanda B, Sheng X, Zhao M, Jia X, Dickerman AW, Beers EP, Brunner AM.

Tree Physiol. 2018 Mar 1;38(3):362-377. doi: 10.1093/treephys/tpx121.

PMID:
29040741

Supplemental Content

Loading ...
Support Center